AZD-1656
- Generic Name
- AZD-1656
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H26N6O5
- CAS Number
- 919783-22-5
- Unique Ingredient Identifier
- 660M185X4D
- Background
AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes).
- Associated Conditions
- -
- Associated Therapies
- -
Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a ...
DelveInsight's report highlights a robust lupus nephritis pipeline with 30+ companies developing 35+ therapies, including key players like AstraZeneca and Novartis. Promising therapies like Anifrolumab and Ianalumab are in various clinical phases, with recent updates from companies like Adicet Bio and Kyverna Therapeutics. The report provides comprehensive insights into the pipeline, therapeutic assessments, and market dynamics.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath